ArticleBMC cancer2022

Diagnostic value of tumor markers in identifying favorable or unfavorable subsets in patients with cancer of unknown primary: a retrospective study.

Shigemasa Takamizawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.